Capsaicin 1%
Dysphagia, Late Effect of Stroke
Georg Kägi, MDPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Dysphagia, Late Effect of Stroke cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Capsaicin Georg Kägi, MD | Phase 2 | CCC |
InOrpha Georg Kägi, MD | Phase 2 | CCC |
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →